日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Real-world untreated risk of hospitalization and death in a nirmatrelvir/ritonavir treatment-eligible population with mild-to-moderate COVID-19 in the United States: a systematic literature review

美国轻度至中度 COVID-19 患者中，符合尼尔马曲韦/利托那韦治疗条件的人群，其未经治疗的真实世界住院和死亡风险：一项系统性文献综述

期刊:BMC Infectious Diseases
影响因子:3
doi:10.1186/s12879-026-12674-3
Migliaccio-Walle, Kristen; Mugwagwa, Tendai; Cha-Silva, Ashley S; Gong, Cynthia L; Campbell, David; Quercia, Romina; Bergroth, Tobias; Veenstra, David L; Moran, Mary M; Dzingina, Mendwas
发表日期：2026
文献求助 收藏

664. Attitudes about COVID and Community Engagement with Patients (ACCEPt): Global Survey Reveals the Ongoing Impact of Long COVID-19 on Medically Vulnerable Populations, Five Years On

664. 关于新冠肺炎的态度和社区患者参与（ACCEPt）：全球调查揭示了新冠肺炎长期症状对医疗弱势群体五年来的持续影响

期刊:International Journal of Womens Health
影响因子:2.6
doi:10.2147/IJWH.S478548
Anto-Ocrah, Martina; Chen, Michael; Affan, Nabeeha Jabir; DeSplinter, Lindsey; Hollenbach, Stefanie; Paredes, Roger; Bodie, Jennifer; Brigden, Nikola; Cardone, Antonella; Cha-Silva, Ashley S; Fernandez, Maria; Gallego, Daniel; Quercia, Romina; Resendez, Jason; Christiane Schmitt, Doris; Spinelli, Frank; Votta, Mariano
肺炎
新冠
微生物学
发表日期：2026
文献求助 收藏

Patient-Reported Outcomes of Nirmatrelvir Treatment for High-Risk, Nonhospitalized Adults With Symptomatic COVID-19

高危、非住院、有症状 COVID-19 成年患者接受尼马替韦治疗的患者报告结局

期刊:Open Forum Infectious Diseases
影响因子:3.8
doi:10.1093/ofid/ofaf449
Ansari, Wajeeha; Coetzer, Henriette; Gebo, Kelly A; Ren, Jinma; Scott, Amie; Cappelleri, Joseph C; Cha-Silva, Ashley S; Leister-Tebbe, Heidi
发表日期：2025
文献求助 收藏

Healthcare Resource Utilization and Cost Comparison Between Palbociclib, Abemaciclib, and Ribociclib Among Patients with HR+/HER2- Metastatic Breast Cancer

帕博西尼、阿贝西利和瑞博西尼在HR+/HER2-转移性乳腺癌患者中的医疗资源利用和成本比较

期刊:
影响因子:
doi:10.2147/CEOR.S496100
Pluard, Timothy J; Sandin, Rickard; Parikh, Rohan C; Ward, Melea Anne; Stansfield, Lindsay; Nham, Tram; Esterberg, Elizabeth; Cha-Silva, Ashley S; Shah, Bhavesh
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Trends in HR+ metastatic breast cancer survival before and after CDK4/6 inhibitor introduction in the United States: a SEER registry analysis of patients with HER2- and HER2+ metastatic breast cancer

美国CDK4/6抑制剂引入前后HR+转移性乳腺癌生存率趋势：基于SEER登记数据的HER2-和HER2+转移性乳腺癌患者分析

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-024-07469-6
Brufsky, Adam; Kwan, Marilyn L; Sandin, Rickard; Stergiopoulos, Stella; Karanth, Siddharth; Cha-Silva, Ashley S; Makari, Doris; Goyal, Ravi K
CDK4
肿瘤
HER2
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Place in Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: A Targeted Literature Review

细胞周期蛋白依赖性激酶4/6抑制剂在乳腺癌治疗中的地位：一项针对性文献综述

期刊:Targeted Oncology
影响因子:4
doi:10.1007/s11523-023-00957-7
Zhao, Melody; Hanson, Kent A; Zhang, Yixie; Zhou, Anna; Cha-Silva, Ashley S
肿瘤
肿瘤免疫
信号转导
乳腺癌
细胞生物学
发表日期：2023
文献求助 收藏

522. Real-World, Retrospective Descriptive Study of COVID-19 Outpatient Therapeutic Uptake in High-Risk Patients Subsequently Hospitalized for COVID-19 During the Omicron Period in the US

522. 美国在 Omicron 计划实施期间，针对高危 COVID-19 患者门诊治疗接受情况的真实世界回顾性描述性研究

期刊:Annals of Botany
影响因子:3.6
doi:10.1093/aob/mcp183
Yu, Shen; Ehrenfeld, Joan G; Scott, Amie; Puzniak, Laura A; Murphy, Michael V; Benjumea, Darrin W; Rava, Andrew; Benigno, Michael; Allen, Kristen E; Stanford, Richard; Manuel, Fadi; Cha-Silva, Ashley S; Jiang, Lili; Reimbaeva, Maya; Draica, Florin
发表日期：2023
文献求助 收藏

Impact of COVID-19 Infection on Health-Related Quality of Life, Work Productivity and Activity Impairment by Symptom-Based Long COVID Status and Age in the US

美国新冠肺炎感染对健康相关生活质量、工作效率和活动能力受损的影响（按症状性新冠长期状况和年龄划分）

期刊:Healthcare
影响因子:2.7
doi:10.3390/healthcare11202790
Di Fusco, Manuela; Cappelleri, Joseph C; Anatale-Tardiff, Laura; Coetzer, Henriette; Yehoshua, Alon; Alvarez, Mary B; Allen, Kristen E; Porter, Thomas M; Puzniak, Laura; Cha-Silva, Ashley S; Lopez, Santiago M C; Sun, Xiaowu
肺炎
新冠
炎症/感染
微生物学
发表日期：2023
文献求助 收藏